(Q45942751)

18 December 2017

title

Early perturbation in feeding behaviour and energy homeostasy in olanzapine-treated rats. (English)

1 reference

18 December 2017

author

Patrick Even

3

1 reference

18 December 2017

author name string

Montserrat Victoriano

1

1 reference

18 December 2017

Dominique Hermier

2

1 reference

18 December 2017

Gilles Fromentin

4

1 reference

18 December 2017

Jean-François Huneau

5

1 reference

18 December 2017

Daniel Tomé

6

1 reference

18 December 2017

Renaud de Beaurepaire

7

1 reference

18 December 2017

publication date

2 July 2009

1 reference

18 December 2017

number of pages

10

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

18 December 2017

volume

206

1 reference

18 December 2017

issue

1

1 reference

18 December 2017

page(s)

167-176

1 reference

18 December 2017

https://scigraph.springernature.com/pub.10.1007/s00213-009-1593-5

exact match

0 references

cites work

Metabolic risk with second-generation antipsychotic treatment: a double-blind randomized 8-week trial of risperidone and olanzapine

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-009-1593-5

Comparative effects of the antipsychotics sulpiride and risperidone in female rats on energy balance, body composition, fat morphology and macronutrient selection

21 January 2018

1 reference

12 December 2020

Effects of chronic neuroleptic treatments on nutrient selection, body weight, and body composition in the male rat under dietary self-selection

1 reference

12 December 2020

Feeding patterns and meal microstructure during development of a taste aversion to a threonine devoid diet

1 reference

12 December 2020

Meal frequency and energy balance

1 reference

12 December 2020

Chronic clozapine treatment in female rats does not induce weight gain or metabolic abnormalities but enhances adiposity: implications for animal models of antipsychotic-induced weight gain

1 reference

12 December 2020

A genome wide linkage study of obesity as secondary effect of antipsychotics in multigenerational families of eastern Quebec affected by psychoses

1 reference

12 December 2020

The distinct effects of subchronic antipsychotic drug treatment on macronutrient selection, body weight, adiposity, and metabolism in female rats

1 reference

12 December 2020

A comparison of the effects of olanzapine and risperidone versus placebo on eating behaviors

1 reference

12 December 2020

An animal model of antipsychotic-induced weight gain

1 reference

12 December 2020

The effects of novel antipsychotics on glucose and lipid levels.

1 reference

12 December 2020

Alterations of lipid metabolism and gene expression in rat adipocytes during chronic olanzapine treatment

1 reference

12 December 2020

Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen

1 reference

12 December 2020

Body weight gain induced by antipsychotic drugs: mechanisms and management

1 reference

12 December 2020

Effects of nibbling and gorging on lipid profiles, blood glucose and insulin levels in healthy subjects.

1 reference

12 December 2020

Long term treatment with olanzapine mixed with the food in male rats induces body fat deposition with no increase in body weight and no thermogenic alteration

1 reference

12 December 2020

The hypothalamic neuropeptide melanin-concentrating hormone acts in the nucleus accumbens to modulate feeding behavior and forced-swim performance.

1 reference

12 December 2020

Meal patterns of free feeding rats treated with clozapine, olanzapine, or haloperidol

1 reference

12 December 2020

Antipsychotic-induced weight gain

1 reference

12 December 2020

Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents

1 reference

12 December 2020

A model for antipsychotic-induced obesity in the male rat.

1 reference

12 December 2020

Acute effects of olanzapine on behavioural expression including the behavioural satiety sequence in female rats

1 reference

12 December 2020

Possible association of the pro-melanin-concentrating hormone gene with a greater body mass index as a side effect of the antipsychotic olanzapine

1 reference

12 December 2020

Effects of olanzapine in male rats: enhanced adiposity in the absence of hyperphagia, weight gain or metabolic abnormalities.

1 reference

12 December 2020

Hyperphagia and increased meal size are responsible for weight gain in rats treated sub-chronically with olanzapine.

1 reference

12 December 2020

Disturbed glucose metabolism among patients taking olanzapine and typical antipsychotics

1 reference

12 December 2020

Consensus development conference on antipsychotic drugs and obesity and diabetes

1 reference

12 December 2020

Antipsychotic medications: metabolic and cardiovascular risk

1 reference

12 December 2020

The melanin-concentrating hormone system of the rat brain: an immuno- and hybridization histochemical characterization

1 reference

12 December 2020

Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics

1 reference

12 December 2020

Clozapine/olanzapine-induced recurrence or deterioration of binge eating-related eating disorders.

1 reference

12 December 2020

Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia

1 reference

12 December 2020

[Precipitation of serum lipoproteins by anionic detergents in the presence of bivalent cations]

1 reference

12 December 2020

Characterisation of olanzapine-induced weight gain and effect of aripiprazole vs olanzapine on body weight and prolactin secretion in female rats

1 reference

12 December 2020

A parametric analysis of olanzapine-induced weight gain in female rats

1 reference

12 December 2020

Antipsychotic-induced weight gain: a comprehensive research synthesis

1 reference

12 December 2020

Blood glucose and schizophrenia: a systematic review of prospective randomized clinical trials.

1 reference

12 December 2020

Effects of dopamine D₁ and dopamine D₂ antagonists on the free feeding and drinking patterns of rats

1 reference

12 December 2020

Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum

1 reference

12 December 2020

Influence of chronic treatment with olanzapine, clozapine and scopolamine on performance of a learned 8-arm radial maze task in rats.

1 reference

12 December 2020

Effects of clozapine, olanzapine and haloperidol on the microstructure of ingestive behaviour in the rat.

1 reference

12 December 2020

Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine

1 reference

12 December 2020

Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide

1 reference

12 December 2020

Clozapine and olanzapine are associated with food craving and binge eating: results from a randomized double-blind study

1 reference

12 December 2020

Zonisamide prevents olanzapine-associated hyperphagia, weight gain, and elevated blood glucose in rats

1 reference

12 December 2020

The metabolic effects of antipsychotic medications

1 reference

12 December 2020

1 reference

12 December 2020

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

12 December 2020

The melanocortins and melanin-concentrating hormone in the central regulation of feeding behavior and energy homeostasis

1 reference

12 December 2020

10.1007/S00213-009-1593-5

Identifiers

DOI

1 reference

18 December 2017

Dimensions Publication ID

1010248553

0 references

1 reference

18 December 2017